Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele-Reference-Cited by-同舟云学术

Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele

Published:2007-08 Issue:4 Volume:21 Page:451-453
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Dorado P.,Peñas-LLedó E.M.,González A.P.,Cáceres M.C.,Cobaleda J.,LLerena A.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1472-8206.2007.00501.x/fullpdf

Reference20 articles.

1. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter

2. The serotonin transporter: a primary target for antidepressant drugs

3. Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region

4. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets

5. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2C19-rs4986893 confers risk to major depressive disorder and bipolar disorder in the Han Chinese population whereas ABCB1-rs1045642 acts as a protective factor;BMC Psychiatry;2023-01-25

2. Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers;International Journal of Neuropsychopharmacology;2023-01-19

3. Investigation of the Serotonergic Activity and the Serotonin Content in Serum and Platelet, and the Possible Role of the Serotonin Transporter in Patients with Depression;Behavioral Sciences;2022-06-03

4. The serotonin transporter gene polymorphism (SLC6A4) and risk for psychiatric morbidity and comorbidity in the Baltimore ECA follow-up study;Comprehensive Psychiatry;2020-10

5. Frequency and risk factors of polypharmacy and drug interactions among patients in general intensive care unit of Golestan Hospital, Ahvaz, southwest of Iran;AIMS Medical Science;2020